🇺🇸 FDA
Patent

US 7468420

Process for purifying glycopeptide phosphonate derivatives

granted A61PA61P31/04

Quick answer

US patent 7468420 (Process for purifying glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P31/04